Dupilumab and tezepelumab in severe refractory asthma: new opportunities
Sign Up to like & getrecommendations! Published in 2022 at "Therapeutic Advances in Chronic Disease"
DOI: 10.1177/20406223221097327
Abstract: Bronchial asthma is a chronic inflammatory condition with increasing prevalence worldwide that may present as heterogeneous phenotypes defined by the T2-mediated pattern of airway inflammation T2-high and T2-low asthma. Severe refractory asthma includes a subset… read more here.
Keywords: dupilumab tezepelumab; refractory; severe refractory; refractory asthma ... See more keywords
Bronchial thermoplasty in patients with dynamic hyperinflation: results from the proof-of-concept HEAT trial
Sign Up to like & getrecommendations! Published in 2020 at "European Respiratory Journal"
DOI: 10.1183/13993003.01616-2020
Abstract: Severe refractory asthma affects 3–5% of asthmatic patients, but represents 50–80% of asthma-related healthcare costs [1]. Although therapies targeting IgE and, more recently, IL5 and IL4/13 have recently gained approval for the treatment of severe… read more here.
Keywords: dynamic hyperinflation; bronchial thermoplasty; refractory asthma; severe refractory ... See more keywords
Clinical Characteristics of Severe Refractory Asthma Associated with the Effectiveness of Bronchial Thermoplasty.
Sign Up to like & getrecommendations! Published in 2019 at "Acta medica Okayama"
DOI: 10.18926/amo/56651
Abstract: We investigated the clinical characteristics of refractory asthma associated with the effectiveness of bronchial thermoplasty (BT). We retrospectively evaluated data from 10 patients who underwent BT between June 2016 and December 2017 at Okayama Medical… read more here.
Keywords: refractory asthma; clinical characteristics; associated effectiveness; effectiveness bronchial ... See more keywords